The present disclosure relates generally to prosthetic valves and more specifically flexible leaflet-type prosthetic heart valve devices.
A number of fabrication techniques have been used to couple the leaflets to a frame, including sewing individual leaflets to the frame (biological and synthetic), and for synthetic leaflets only, injection molding and dip coating a polymer onto the frame. In many cases, the resulting leaflet is supported on the frame and defines a flap having a mounting edge where the leaflet is coupled to the frame and a free edge that allows the flap to move. The flap moves under the influence of fluid pressure. In operation, the leaflets open when the upstream fluid pressure exceeds the downstream fluid pressure and closes when the downstream fluid pressure exceeds the upstream fluid pressure. The free edges of the leaflets coapt under the influence of downstream fluid pressure, closing the valve to prevent downstream blood from flowing retrograde through the valve.
Valve durability under the repetitive loads of the leaflets opening and closing is dependent, in part, on the load distribution between the leaflet and the frame. Further, substantial load is encountered on the leaflet when in the closed position. Mechanical failure of the leaflet can arise, for example, at the mounting edge, where the flexible leaflet is supported by the relatively rigid frame, particularly at the commissure posts. The repetitive loads of leaflet opening and closing leads to material failure by fatigue, creep or other mechanism, depending in part on the leaflet material. Mechanical failure at the mounting edge is especially prevalent with synthetic leaflets.
There remains a need for a more durable flexible leaflet prosthetic valve.
Described embodiments are directed to apparatus, system, and methods for valve replacement, such as cardiac valve replacement. More specifically, described embodiments are directed toward flexible leaflet valve devices having biological or synthetic leaflet material and a frame, and methods of making and implanting the valve devices.
According to an embodiment, a prosthetic heart valve comprises a leaflet frame assembly. The leaflet frame assembly is an assembly of a leaflet frame, leaflet construct, and retention elements. The leaflet construct is that portion of the valve that comprises the leaflets and the structure for coupling the leaflets to the leaflet frame. In accordance with an embodiment, the leaflet construct defines a contiguous annular ring defining a plurality of leaflets and a bridge region between each of the leaflets. Each bridge region defines a bridge first end adjacent a first leaflet and a bridge second end adjacent a second leaflet. The leaflets extend radially inward from the leaflet frame when coupled to the leaflet frame. Each of the leaflets defines a fold-over portion that is folded over and lies against a leaflet frame outer side of the leaflet frame and coupled thereto such as with a securement structure, such as, but not limited to suture, adhesive, thermal bonding, or other means. Each of the bridge regions defines a bridge loop with a coaptation neck between the bridge loop and the adjacent leaflets. The coaptation neck is operable to pass through one of the post slots so that the bridge loop is adjacent to the outer portion of the leaflet frame and the leaflets extend radially inward from the leaflet frame. A retention element is disposed within the bridge loop effectively preventing the bridge loop from passing through the post slot. The retention element may be coupled to the commissure post, such as with a securement structure, such as, but not limited to suture, adhesive, thermal bonding, or other means. The fold-over portion of each of the leaflets is folded around an inflow edge of the leaflet frame and coupled thereto, such as with a securement structure, such as, but not limited to suture, adhesive, thermal bonding, or other means.
A method of making a prosthetic valve, in accordance with an embodiment, comprises obtaining a tube comprising one or more layers of expanded PTFE composite. Cutting a leaflet construct including a plurality of leaflets each being separated by a bridge region from the tube. Providing fold-over apertures in fold-over portions of the leaflets and bridge apertures in the bridge region. Obtaining a plurality of retention elements, each retention element defining retention element apertures. Folding each of the bridge regions into a bridge loop and defining a coaptation neck between each bridge loop and two adjacent leaflets, the bridge loops extending radially away from the tube axis. Disposing a retention element into each of the bridge loops. Suturing each retention element to the respective bridge loop passing suture through the bridge apertures and the retention element apertures that are aligned therewith. Cutting a leaflet frame from a metal tube defining leaflet frame windows and commissure posts therebetween where each commissure post defines a post slot dimensioned to receive a double thickness of the bridge region. Providing leaflet window frame apertures in the leaflet window frame and post apertures in the commissure posts. Disposing each coaptation neck in a respective post slot with the retention elements adjacent the post outer side and disposing the leaflets in the leaflet frame. Aligning the retention element apertures with the post apertures. Suturing each retention element to the respective commissure post passing suture through the retention element apertures and the post apertures that are aligned therewith. Folding the fold-over portions of each leaflet along the leaflet frame inflow edge and against the leaflet frame outer side aligning the fold-over apertures with the leaflet window frame apertures. And suturing each fold-over portion to the respective leaflet window frame passing suture through the fold-over apertures and the leaflet window frame apertures that are aligned therewith.
The accompanying drawings are included to provide a further understanding of the present disclosure and are incorporated in and constitute a part of this specification, illustrate embodiments described herein, and together with the description serve to explain the principles discussed in this disclosure.
Persons skilled in the art will readily appreciate that various aspects of the present disclosure can be realized by any number of methods and apparatus configured to perform the intended functions. Stated differently, other methods and apparatus can be incorporated herein to perform the intended functions. It should also be noted that the accompanying drawing figures referred to herein are not necessarily drawn to scale, but may be exaggerated to illustrate various aspects of the present disclosure, and in that regard, the drawing figures should not be construed as limiting.
Although the embodiments herein may be described in connection with various principles and beliefs, the described embodiments should not be bound by theory. For example, embodiments are described herein in connection with prosthetic valves, more specifically cardiac prosthetic valves. However, embodiments within the scope of this disclosure can be applied toward any valve or mechanism of similar structure and/or function. Furthermore, embodiments within the scope of this disclosure can be applied in non-cardiac applications.
The term leaflet as used herein in the context of prosthetic valves is a flexible component of a one-way valve wherein the leaflet is operable to move between an open and closed position under the influence of a pressure differential. In an open position, the leaflet allows blood to flow through the valve. In a closed position, the leaflet substantially blocks retrograde flow through the valve. In embodiments comprising multiple leaflets, each leaflet cooperates with at least one neighboring leaflet to block the retrograde flow of blood. The pressure differential in the blood is caused, for example, by the contraction of a ventricle or atrium of the heart, such pressure differential typically resulting from a fluid pressure building up on one side of the leaflets when closed. As the pressure on an inflow side of the valve rises above the pressure on the outflow side of the valve, the leaflets open and blood flows therethrough. As blood flows through the valve into a neighboring chamber or blood vessel, the pressure on the inflow side equalizes with the pressure on the outflow side. As the pressure on the outflow side of the valve raises above the blood pressure on the inflow side of the valve, the leaflet returns to the closed position generally preventing retrograde flow of blood through the valve.
The term membrane as used herein refers to a sheet comprising a single material, such as, but not limited to, expanded fluoropolymer.
The term composite material as used herein refers to a combination of a membrane, such as, but not limited to, expanded fluoropolymer, and an elastomer, such as, but not limited to, a fluoroelastomer. The elastomer can be contained within a porous structure of the membrane, coated on one or both sides of the membrane, or a combination of coated on and contained within the membrane.
The term laminate as used herein refers to multiple layers of membrane, composite material, or other materials, such as elastomer, and combinations thereof.
The term film as used herein generically refers to one or more of the membrane, composite material, or laminate.
The term biocompatible material as used herein generically refers to any material with biocompatible characteristics including synthetic, such as, but not limited to, a biocompatible polymer, or a biological material, such as, but not limited to, bovine pericardium.
The terms native valve orifice and tissue orifice refer to an anatomical structure into which a prosthetic valve can be placed. Such anatomical structure includes, but is not limited to, a location wherein a cardiac valve may or may not have been surgically removed. It is understood that other anatomical structures that can receive a prosthetic valve include, but are not limited to, veins, arteries, ducts and shunts. It is further understood that a valve orifice or implant site may also refer to a location in a synthetic or biological conduit that may receive a valve.
As used herein, “couple” means to join, connect, attach, adhere, affix, or bond, whether directly or indirectly, and whether permanently or temporarily.
Embodiments herein include various apparatus, systems, and methods for a prosthetic valve, such as, but not limited to, cardiac valve replacement. The valve is operable as a one-way valve wherein the valve defines a valve orifice into which leaflets open to permit flow and close so as to occlude the valve orifice and prevent flow in response to differential fluid pressure.
Leaflet Frame
The leaflet frame 200 is operable to hold and support the leaflet construct 300. The leaflet frame 200 is annular, that is it defines a cylinder having an axis X and a plurality of commissure posts 210 extending parallel to the axis x that are spaced from one another, each commissure post 210 defining a post slot 217 therethrough that is aligned parallel to the axis X. Between the commissure posts 210 is a leaflet window 222 that is operable to couple to and support the leaflet 310 around the perimeter of the leaflet 310 except for the leaflet free edge 312.
The leaflet frame 200 defines a cylinder having a leaflet frame inner side 202 and a leaflet frame outer side 204 opposite the leaflet frame inner side 202. The leaflet frame 200 further defines a plurality of commissure posts 210. Each commissure post 210 has a post outer side 212 and a post inner side 214 opposite the post outer side 212. The commissure post 210 is defined by a first post leg 216 and a second post leg 218 separated by a post slot 217 therebetween. A commissure tip 219 couples the first post leg 216 and the second post leg 218.
In accordance with an embodiment, the leaflet frame 200 is annular about a central longitudinal axis X of the valve 100 as shown in
The leaflet frame 200 can be etched, cut, laser cut, stamped, three-dimensional printed, among other suitable processes, into an annular structure or a sheet of material, with the sheet then formed into an annular structure.
The leaflet frame 200 can comprise, such as, but not limited to, any elastically deformable metallic or polymeric material that is generally biocompatible. The leaflet frame 200 can comprise a shape-memory material, such as nitinol, a nickel-titanium alloy. Other materials suitable for the leaflet frame 200 include, but not limited to, other titanium alloys, stainless steel, cobalt-nickel alloy, polypropylene, acetyl homopolymer, acetyl copolymer, other alloys or polymers, or any other material that is generally biocompatible having adequate physical and mechanical properties to function as a leaflet frame 200 as described herein.
Leaflet Construct
The leaflet construct 300 is that portion of the valve 100 that comprises the leaflets 310 and the structure for coupling the leaflets 310 to the leaflet frame 200. In accordance with an embodiment, the leaflet construct 300 defines a contiguous annular ring defining a plurality of leaflets 310 and a bridge region 330 between each of the leaflets 310. As used herein, contiguous means without a break or a seam, that is, seamless. Each bridge region defines a bridge first end 332 adjacent a first leaflet 310 and a bridge second end 334 adjacent a second leaflet 310. The leaflets extend radially inward from the leaflet frame 200 when coupled to the leaflet frame 200. Each of the leaflets 310 define a fold-over portion 324 that is folded over and lies against a leaflet frame outer side 204 of the leaflet frame 200 and coupled thereto. Each of the bridge regions 330 defines a bridge loop 338 with a coaptation neck 340 between the bridge loop 338 and the adjacent leaflets 310. The coaptation neck 340 is operable to pass through one of the post slots 217 so that the bridge loop 338 is adjacent to the outer portion of the leaflet frame 200 and the leaflets 310 extend radially inward from the leaflet frame 200.
The leaflet construct 300 comprising the flexible leaflets 310 can be made of polymer. For example, pre-shaped polymer leaflets can be made by starting from a cylinder of polymer material that has been cut into a shape like that shown in
The leaflet construct 300 can also be made from a sheet of polymer material that has been cut into a shape like that shown in
Another way that the leaflet construct 300 may be formed (assuming the use of a material for the leaflets that is suitable for formation in this way) is by compression or injection molding.
In accordance with an embodiment, each leaflet 310, at the folds 326, has substantially the shape of an isosceles trapezoid having two leaflet sides 323, a leaflet base 325 and a leaflet free edge 312 opposite the leaflet base 325, corresponding to the two leaflet window sides 223 and a leaflet window base 225. The two leaflet sides 323 diverge from the leaflet base 325, wherein the leaflet base 325 is substantially flat.
In accordance with other embodiments of the valve 100, each leaflet 310 includes a central region 329 and two side regions 328 on opposite sides of the central region 329. The central region 329 is defined by a shape substantially that of an isosceles trapezoid defined by two central region sides 327, the leaflet base 325 and the leaflet free edge 312. Each of the side regions 328 has a shape substantially that of a triangle and each are defined by one of the central region sides 327, one of the leaflet sides 323, and the leaflet free edge 312.
In accordance with another embodiment, the leaflet window may be described as having a U-shape. The leaflet frame generally defines a plurality of U-shaped portions as one proceeds annularly around the leaflet frame, defining a plurality of commissure posts and a plurality of leaflet window frame portions.
As shown in
Between each of the leaflets 310 is a bridge region 330, as shown in
In accordance with an embodiment, the leaflet construct 300 can comprise a biocompatible material that is not of a biological source and that is sufficiently compliant and strong for the particular purpose, such as a biocompatible polymer. In an embodiment, the leaflet construct 300 comprises a membrane that is combined with an elastomer to form a composite material. In accordance with other embodiments, the biocompatible material that makes up the leaflet construct 300 comprises a biological material, such as, but not limited to, bovine pericardium.
The shape of the leaflets 310 are defined in part by the shape of the leaflet frame 200 and the leaflet free edge 312. The shape of the leaflets 310 can also be defined by the structures and processes used to manufacture the valve 100, such as, but not limited, those described below. For example, in accordance with an embodiment, the shape of the leaflets 310 also depends in part on molding the leaflets 310 using molding and trimming processes to impart a predetermined shape to the leaflet 310.
The leaflets 310 generally flex about the leaflet base 325 about the leaflet window base 225 of the U-shaped portion as the leaflets 310 open and close. In an embodiment, when the valve 100 is closed, generally about half of each leaflet free edge 312 abuts an adjacent half of a leaflet free edge 312 of an adjacent leaflet 310, as shown in
Leaflet Construct Material
The leaflet construct 300 can comprise any biocompatible material sufficiently compliant and flexible, such as a biocompatible polymer. The leaflet construct 300 can comprise a membrane that is combined with an elastomer to form a composite material. The leaflet construct 300 can comprise, according to an embodiment, a composite material comprising an expanded fluoropolymer membrane, which comprises a plurality of spaces within a matrix of fibrils, and an elastomeric material. It should be appreciated that multiple types of fluoropolymer membranes and multiple types of elastomeric materials can be combined to form a composite material while remaining within the scope of the present disclosure. It should also be appreciated that the elastomeric material can include multiple elastomers, multiple types of non-elastomeric components, such as inorganic fillers, therapeutic agents, radiopaque markers, and the like while remaining within the scope of the present disclosure.
In accordance with an embodiment, the composite material includes an expanded fluoropolymer material made from porous ePTFE membrane, for instance as generally described in U.S. Pat. No. 7,306,729 to Bacino.
The expandable fluoropolymer, used to form the expanded fluoropolymer material described, can comprise PTFE homopolymer. In alternative embodiments, blends of PTFE, expandable modified PTFE and/or expanded copolymers of PTFE can be used. Non-limiting examples of suitable fluoropolymer materials are described in, for example, U.S. Pat. No. 5,708,044, to Branca, U.S. Pat. No. 6,541,589, to Baillie, U.S. Pat. No. 7,531,611, to Sabol et al., U.S. patent application Ser. No. 11/906,877, to Ford, and U.S. patent application Ser. No. 12/410,050, to Xu et al.
The expanded fluoropolymer membrane can comprise any suitable microstructure, such as pores, for achieving the desired leaflet performance. Other biocompatible polymers which can be suitable for use in leaflet include but are not limited to the groups of urethanes, silicones (organopolysiloxanes), copolymers of silicon-urethane, styrene/isobutylene copolymers, polyisobutylene, polyethylene-co-poly(vinyl acetate), polyester copolymers, nylon copolymers, fluorinated hydrocarbon polymers and copolymers or mixtures of each of the foregoing.
Further examples of leaflet construct materials include: wherein the leaflet construct comprises at least one fluoropolymer membrane layer; wherein the leaflet construct comprises a laminate having more than one fluoropolymer membrane layer; wherein the at least one fluoropolymer membrane layer is an expanded fluoropolymer membrane layer; wherein an elastomer is contained within the expanded fluoropolymer membrane layer; wherein the elastomer comprises perfluoromethyl vinyl ether and tetrafluoroethylene; wherein the expanded fluoropolymer membrane layer comprises ePTFE; wherein the leaflet construct comprises a composite material having at least one fluoropolymer membrane layer having a plurality of pores and an elastomer present in the pores of at least one of the fluoropolymer membrane layers; wherein the composite material comprises fluoropolymer membrane by weight in a range of about 10% to 90%; wherein the elastomer comprises (per)fluoroalkylvinylethers (PAVE); wherein the elastomer comprises a copolymer of tetrafluoroethylene and perfluoromethyl vinyl ether; wherein the elastomer is silicone; wherein the elastomer is a fluoroelastomer; wherein the elastomer is a urethane; and wherein the elastomer is a TFE/PMVE copolymer; wherein the TFE/PMVE copolymer comprises essentially of between about 40 and 80 weight percent perfluoromethyl vinyl ether and complementally 60 and 20 weight percent tetrafluoroethylene; and wherein the leaflet construct comprises silicone.
Retention Element
The retention element 400 is an element that is operable to be disposed within the bridge loop 338 formed by the bridge region 330 of the leaflet construct 300, which effectively prevents the bridge loop 338 from passing through the post slot 217, and therefore the leaflet construct 300 is mechanically coupled to the commissure post at the post outer side. The retention element 400 has a width that is larger than a width of the post slot 217. With the retention element 400 being disposed in the bridge loop 338, the bridge loop 338 will be prevented from passing through the post slot 217. The size of the bridge loop 338 should correspond closely to the size of the retention element 400 to prevent a portion of the bridge region 330 from extending through the post slot 217 to the valve orifice 150 in case of the suture loosening or failing.
In accordance with an embodiment, the retention element 400 defines a relatively flat generally rectangular shape so as to have a low profile on the post outer side 212 of the commissure post 210. Due to the curvature of the annular leaflet frame 200, the sides of the retention element 400 are formed at an angle corresponding to the two loop fold lines 336 that form an angle alpha, as shown in
In accordance with embodiments, the retention element 400 can be flat, relatively flat, or concave on the inside (toward the center of the valve) to correspond with the radially outer convexity of commissure post 210 that the retention element 400 will be adjacent to. Each retention element 400 has a plurality of retention element apertures 408 that align with commissure post apertures 209 wherein the retention element 400 is placed against the post outer side 212 of the commissure post 210 with a portion of the bridge region 330 therebetween. A securement structure, such as, but not limited to suture 700, may be used to couple the retention element 400 to the commissure post 210. Suture may be of any suitable material, such as PTFE, PET, and nylon, among others. Stitching comprising suture 700 may be passed through these aligned commissure post apertures 209 and retention element apertures 408 and the bridge region 330 to hold each retention element 400 and the bridge region 330 to the commissure post 210. Some or all of this suture 700 may pass through the fold-over portion 324 of the leaflet 310. In that event, this suture 700 will contribute to securing the leaflet belly portion 322 of the leaflets 310 to the leaflet frame 200.
Examples of suitable materials for the retention elements 400 include various biocompatible alloys such as titanium, Elgiloy, MP35N, stainless steel, nitinol, etc., and various biocompatible engineering plastics such as acetyl polymers, PTFE, and PEEK.
Leaflet Frame Assembly
A leaflet frame assembly 234 is the assembly of the leaflet frame 200, leaflet construct 300, and the retention elements 400. The leaflet construct 300 is that portion of the valve 100 that comprises the leaflets 310 and the structure for coupling the leaflets 310 to the leaflet frame 200. In accordance with an embodiment, the leaflet construct 300 defines a contiguous cylinder defining a plurality of leaflets 310 and a bridge region 330 between each of the leaflets 310. Each bridge region defines a bridge first end 332 adjacent a first leaflet 310 and a bridge second end 334 adjacent a second leaflet 310. The leaflets extend radially inward from the leaflet frame 200 when coupled to the leaflet frame 200. Each of the leaflets 310 defines a fold-over portion 324 that is folded over and lies against a leaflet frame outer side 204 of the leaflet frame 200 and coupled thereto, such as with securement structure, such as, but not limited to suture, adhesive, thermal bonding, or other means. Each of the bridge regions 330 defines a bridge loop 338 with a coaptation neck 340 between the bridge loop 338 and the adjacent leaflets 310. The coaptation neck 340 is operable to pass through one of the post slots 217 so that the bridge loop 338 is adjacent to the outer portion of the leaflet frame 200 and the leaflets 310 extend radially inward from the leaflet frame 200. A retention element 400 is disposed within the bridge loop 338 effectively preventing the bridge loop 338 from passing through the post slot 217. The retention element 400 may be coupled to the commissure post 210, such as with suture, adhesive, thermal bonding, or other means. The fold-over portion 324 of each of the leaflets 310 is folded around an inflow edge of the leaflet frame 200 and coupled thereto, such as with suture, adhesive, thermal bonding, or other means.
In accordance with an embodiment, each bridge region 330 is wrapped around a retention element outer side 412 to the retention element inner side 414 of one of the retention elements 400 with the bridge first end 332 wrapped across the retention element inner side 414 to adjacent a dividing line 416 that vertically bisects the retention element 400, from a first direction and the bridge second end 334 wrapped across the retention element inner side 414 to adjacent the dividing line 416 from an opposite direction, wherein the bridge first end 332 and bridge second end 334 are adjacent to each other to define a coaptation neck 340.
In accordance with an embodiment, the leaflet frame assembly 234 is provided with means for coupling to a native tissue annulus, and thus the leaflet frame assembly 234 is a prosthetic heart valve 100. In an embodiment, a sewing cuff 600 is coupled to the leaflet frame assembly 234, where the sewing cuff is operable to be sutured to the native tissue annulus. In another embodiment, a base frame 500 comprising a sewing cuff 600 is coupled to the leaflet frame assembly 234.
One possible way to characterize the benefits of some embodiments presented herein is the effect of the bridge region 330 being a continuous member, that is, no seams or breaks. Any force tending to pull or extract the bridge region 330 through the post slot 217 is countered by the tensile strength of the material that the bridge region 330 comprises. The forces on the leaflets 310 during use are greatest at the commissure posts 210 tending to pull the leaflets 310 away from the commissure posts 210. The coupling of the leaflet construct 300 to the leaflet frame 200 at the commissure posts 210, in accordance with these embodiments, does not rely solely on the suture 700 but also the retention element 400 that prevents the bridge region 330 from passing through the post slot 217. It is understood that sutures, in general, tend to loosen and fail over a period of time, especially in regions of high stress. In these embodiments, the suture 700 that couples the bridge region 330 to the commissure post 210 may loosen or fail but the retention element 400 continues to prevent the bridge region 330 from passing through the post slot 217 preventing failure of the valve 100.
Further, the retention element 400 provides a clamping force between a portion of the bridge region 330 and the post outer side 212 of the commissure post 210 during operation of the valve 100. This clamping force is the result of the retention element 400 being larger than the post slot 217 which prevents the bridge region 330 from passing through the post slot 217. The clamping force does not rely on the strength of the suture 700 or the tension of the suture on the bridge region 330 and the commissure posts 210.
This clamping force may tend to distribute the forces on the bridging region 330 reducing peak stresses that might be applied at the suture 700 and apertures 999. Further the clamping force is the primary mode of transferring the forces from the leaflets 130 to the leaflet frame 200 rather than merely relying on the stitching of the leaflets 310 to the leaflet frame 200. Further, the angle alpha of the two loop fold lines 336 allows for a substantially equal distribution of stresses over the coaptation neck 340 between the bridge loop 338 and the adjacent leaflets 310 whereby reducing the peak stresses in the coaptation neck 340.
In accordance with these embodiments, the leaflets 310 extend perpendicular from the leaflet frame 200, as shown in
The design and manufacturing process (including the various components and the way of assembling those components) greatly reduce possible stress concentration at the leaflet frame-leaflet junction by distributing the load more evenly. These design and manufacturing process aspects also (1) reduce the burden of extensive and demanding suturing, (2) increase the consistency of valve manufacturing results, and (3) increase the service life of a resulting valve as a consequence of all of the foregoing factors.
Instead of or in addition to suture, chemical bonds and/or adhesives can be used between the leaflet frame 200 and the fold-over portion 324 of the leaflet construct.
The bridge regions 330 are passed through the post slot 217 in a number of ways. In accordance with an embodiment, the bridge region 330 is formed into a narrow bridge loop 338 which is passed through the post slot 217 from the leaflet frame inner side 202 to the leaflet frame outer side 204. A retention element 400 may then be inserted into the bridge loop 338 preventing the bridge loop 338 from being passed back through the post slot 217.
In accordance with embodiments, the leaflet frame 200, leaflet construct 300 and the retention elements 400 have matching and radially aligned apertures for receiving suture. The fold-over portion 324 and the bridge regions 330 containing a retention element 400 are coupled to the leaflet frame by suturing through these matching apertures. The dashed lines in
Base Frame
The base frame 500 is a generally annular member defining a base frame lumen 550 having a base frame inner side 502 and a base frame outer side 504, as shown in
In accordance with an embodiment, the base frame 500 defines a plurality of triangular regions 526 extending away from the base frame inflow edge 520. The leaflet frame 200 may comprise corresponding triangular openings 256 defined by two leaflet window sides 223 of adjacent leaflet windows 222 of the leaflet frame 200 define two sides of an isosceles triangle on the leaflet frame inflow edge 220. The triangular openings 256 are operable to receive the triangular regions 526 of the base frame 500 therein.
The base frame 500 can comprise any metallic or polymeric material that is generally biocompatible. For example, the base frame 500 can comprise a material, such as, but not limited to nitinol, cobalt-nickel alloy, stainless steel, and polypropylene, acetyl homopolymer, acetyl copolymer, ePTFE, other alloys or polymers, or any other biocompatible material having adequate physical and mechanical properties to function as described herein.
The base frame 500 can be etched, cut, laser cut, or stamped into a tube or a sheet of material, with the sheet then formed into an annular structure.
In accordance with embodiments, the base frame 500 can be configured to provide positive engagement to an implant site. In an embodiment, the valve 100 further includes a sewing cuff 600 coupled about the base frame 500, as shown in
It is appreciated that other elements or means for coupling the valve 100 to an implant site are anticipated. By way of example, but not limited thereto, other means, such as mechanical and adhesive means may be used to couple the valve 100 to a synthetic or biological conduit.
In another embodiment, the valve 100 further comprises a base frame 500, as shown in
In embodiments of the valve 100, the inclusion of a base frame 500 and a leaflet frame 200 provides a means for providing different physical properties for each of the base frame 500 and the leaflet frame 200 suitable for a particular purpose. In accordance with an embodiment, the base frame 500 is stiffer as compared with the leaflet frame 200. The base frame 500, when engaged to the implant site, such as, but not limited to a tissue orifice, is rigid enough to not significantly deform under physiological loading.
The physical properties of the base frame 500 and the leaflet frame 200 depends, in part, on the size, shape, thickness, and material property of the base frame 500 and the leaflet frame 200.
Stiff and stiffness, as used herein and as is commonly used in engineering, is a measure of the resistance to deformation given by a base. Stiff and stiffness is a function of, among other things, material properties, the shape of the object, and the boundary conditions on the object. Stiffness of the leaflet frame 200 (see
Sewing Cuff
The valve 100 may be provided with a sewing cuff 600 adjacent the base frame 500, as shown in
Methods
A method of making a prosthetic valve, in accordance with embodiment, comprises obtaining a tube comprising one or more layers of expanded PTFE composite. Cutting a leaflet construct including a plurality of leaflets each being separated by a bridge region from the tube. Providing fold-over apertures in fold-over portions of the leaflets and bridge apertures in the bridge region. Obtaining a plurality of retention elements, each retention element defining retention element apertures. Folding each of the bridge regions into a bridge loop and defining a coaptation neck between each bridge loop and two adjacent leaflets, the bridge loops extending radially away from the tube axis. Disposing a retention element into each of the bridge loops. Suturing each retention element to the respective bridge loop passing suture through the bridge apertures and the retention element apertures that are aligned therewith. Cutting a leaflet frame from a metal tube defining leaflet frame windows and commissure posts therebetween where each commissure post defines a post slot dimensioned to receive a double thickness of the bridge region. Providing leaflet window frame apertures in the leaflet window frame and post apertures in the commissure posts. Disposing each coaptation neck in a respective post slot with the retention elements adjacent the post outer side and disposing the leaflets in the leaflet frame. Aligning the retention element apertures with the post apertures. Suturing each retention element to the respective commissure post passing suture through the retention element apertures and the post apertures that are aligned therewith. Folding the fold-over portions of each leaflet along the leaflet frame inflow edge and against the leaflet frame outer side aligning the fold-over apertures with the leaflet window frame apertures. And suturing each fold-over portion to the respective leaflet window frame passing suture through the fold-over apertures and the leaflet window frame apertures that are aligned therewith.
In accordance with an embodiment the method may further comprise providing strips of fabric, wrapping and sewing the fabric on the leaflet frame to provide a cushion between the leaflet frame and the leaflet construct, and trimming the fabric to approximately 3 mm from the leaflet frame outflow edge of the leaflet frame.
In accordance with an embodiment the method may further comprise cutting a base frame from a metal tube defining base frame apertures, and coupling the base frame to the leaflet frame inflow edge of the leaflet frame.
In accordance with an embodiment the method may further comprise providing a fabric tube and inserting the fabric tube through the base frame along its flow axis. Folding the fabric outflow edge of the fabric over the base frame outflow edge of the base frame. Sewing the fabric into place using suture through the base frame apertures in the base frame. Inverting the fabric inflow edge of the fabric tube over the base frame. Sewing the fabric tube into place using suture through base frame apertures along the inflow edge of the base frame. Disposing a sewing cuff insert inside a pocket defined by the inverted fabric tube and tucking the fabric tube in between the base frame and the sewing cuff insert such that all the slack of the fabric tube is removed around the sewing cuff. Placing the leaflet frame coaxially with and adjacent to the base frame and inside the fabric tube. Trimming the fabric tube approximately 5 mm from the leaflet frame outflow edge and suturing the leaflet frame to the base frame at the leaflet window base using suture passing through the respective leaflet window frame apertures and the base frame apertures. Folding the trimmed edge of the fabric tube over the leaflet frame outflow edge, tucking the trimmed edge underneath itself to conceal any frayed edges, and sewing the fabric tube to the fabric on the leaflet frame.
By way of example, one embodiment of a valve was made as follows:
A surgical prosthetic heart valve was constructed in the following manner. A leaflet construct 300, including fold-over apertures 308 and bridge apertures 309, was cut from the leaflet coupon using a CO2 laser according to the pattern shown in
Three retention elements 400 made from PEEK, shown in
A leaflet frame 200 and base frame 500 were laser cut, including leaflet frame apertures 208 and base frame apertures 508, respectively, and electropolished from a tube of cobalt chromium (MP35N) with a 25 mm OD and 0.4 mm wall thickness, as shown in
A tube of polyester knit fabric about 24 mm in diameter and at least 10 cm in length was inserted through the base frame 500 along its flow axis. The fabric outflow edge of the polyester knit fabric was folded over the base frame outflow edge 524 of the base frame 500 and sewn into place using suture 700 through base frame apertures 508 in the base frame 500 (not shown). The fabric inflow edge of the polyester knit fabric tube was inverted over the base frame 500 and sewn into place using suture 700 through base frame apertures 508 along the base frame inflow edge 520 of the base frame 500. A silicone sewing cuff insert was placed over the base frame 500 and inside of the inverted polyester knit fabric tube. The polyester knit fabric tube was tucked in between the base frame 500 and the sewing cuff insert such that all the slack was removed around the sewing cuff 600.
The leaflet frame assembly 234 comprising the leaflet frame 200, the leaflet construct 300 and retention elements 400 was coaxially placed adjacent the base frame and inside the polyester knit fabric tube. The polyester knit fabric tube was trimmed approximately 5 mm off the leaflet frame outflow edge 224. The leaflet frame 200 was sutured to the base frame 500 at the leaflet window base 225, with three sutures 700 at each of the three leaflet window bases 225 of the leaflet frame 200. The trimmed edge of the polyester knit fabric was folded over the leaflet frame outflow edge 224. The trimmed edge was tucked underneath itself to conceal any frayed edges and sewn to the polyester knit fabric on the leaflet frame.
Numerous characteristics and advantages have been set forth in the preceding description, including various alternatives together with details of the structure and function of the devices and/or methods. The disclosure is intended as illustrative only and as such is not intended to be exhaustive. It will be evident to those skilled in the art that various modifications can be made, especially in matters of structure, materials, elements, components, shape, size and arrangement of parts including combinations within the principles of the disclosure, to the full extent indicated by the broad, general meaning of the terms in which the appended claims are expressed. To the extent that these various modifications do not depart from the spirit and scope of the appended claims, they are intended to be encompassed therein.
This application is a continuation of U.S. patent application Ser. No. 15/791,562, filed Oct. 24, 2017, which is a continuation of U.S. patent application Ser. No. 14/853,654, filed Sep. 14, 2015, now U.S. Pat. No. 9,827,094, issued Nov. 28, 2017, which claims the benefit of U.S. Provisional Application 62/050,628, filed Sep. 15, 2014, all of which are incorporated herein by reference in their entireties for all purposes.
Number | Name | Date | Kind |
---|---|---|---|
654799 | Levett | Jul 1900 | A |
3739402 | Kahn et al. | Jun 1973 | A |
3953566 | Gore | Apr 1976 | A |
4178639 | Bokros | Dec 1979 | A |
4187390 | Gore | Feb 1980 | A |
4222126 | Boretos et al. | Sep 1980 | A |
4265694 | Boretos et al. | May 1981 | A |
4332035 | Mano | Jun 1982 | A |
4340091 | Skelton et al. | Jul 1982 | A |
4477930 | Totten et al. | Oct 1984 | A |
4556996 | Wallace | Dec 1985 | A |
4626255 | Reichart et al. | Dec 1986 | A |
4759759 | Walker et al. | Jul 1988 | A |
4851000 | Gupta | Jul 1989 | A |
4877661 | House et al. | Oct 1989 | A |
4955899 | Della et al. | Sep 1990 | A |
5026513 | House et al. | Jun 1991 | A |
5064435 | Porter | Nov 1991 | A |
5071609 | Tu et al. | Dec 1991 | A |
5123918 | Perrier et al. | Jun 1992 | A |
5163955 | Love et al. | Nov 1992 | A |
5415667 | Frater | May 1995 | A |
5469868 | Reger | Nov 1995 | A |
5476589 | Bacino | Dec 1995 | A |
5489297 | Duran | Feb 1996 | A |
5534007 | St et al. | Jul 1996 | A |
5549663 | Cottone, Jr. | Aug 1996 | A |
5554183 | Nazari | Sep 1996 | A |
5554185 | Block et al. | Sep 1996 | A |
5562729 | Purdy | Oct 1996 | A |
5628791 | Bokros et al. | May 1997 | A |
5673102 | Suzuki et al. | Sep 1997 | A |
5708044 | Branca | Jan 1998 | A |
5718973 | Lewis et al. | Feb 1998 | A |
5749852 | Schwab et al. | May 1998 | A |
5752934 | Campbell et al. | May 1998 | A |
5759192 | Saunders | Jun 1998 | A |
5769884 | Solovay | Jun 1998 | A |
5772884 | Tanaka et al. | Jun 1998 | A |
5788626 | Thompson | Aug 1998 | A |
5814405 | Branca et al. | Sep 1998 | A |
5824043 | Cottone, Jr. | Oct 1998 | A |
5843158 | Lenker et al. | Dec 1998 | A |
5843161 | Solovay | Dec 1998 | A |
5843171 | Campbell et al. | Dec 1998 | A |
5853419 | Imran | Dec 1998 | A |
5925061 | Ogi et al. | Jul 1999 | A |
5928281 | Huynh et al. | Jul 1999 | A |
5935162 | Dang | Aug 1999 | A |
5935163 | Gabbay | Aug 1999 | A |
5944654 | Crawford | Aug 1999 | A |
5957974 | Thompson et al. | Sep 1999 | A |
6010529 | Herweck et al. | Jan 2000 | A |
6013854 | Moriuchi | Jan 2000 | A |
6019785 | Strecker | Feb 2000 | A |
6042588 | Munsinger et al. | Mar 2000 | A |
6042605 | Martin et al. | Mar 2000 | A |
6042606 | Frantzen | Mar 2000 | A |
6086612 | Jansen | Jul 2000 | A |
6110198 | Fogarty et al. | Aug 2000 | A |
6117169 | Moe | Sep 2000 | A |
6129758 | Love | Oct 2000 | A |
6161399 | Jayaraman | Dec 2000 | A |
6165211 | Thompson | Dec 2000 | A |
6171335 | Wheatley et al. | Jan 2001 | B1 |
6174329 | Callol et al. | Jan 2001 | B1 |
6174331 | Moe et al. | Jan 2001 | B1 |
6190406 | Duerig et al. | Feb 2001 | B1 |
6197143 | Bodnar | Mar 2001 | B1 |
6217609 | Haverkost | Apr 2001 | B1 |
6245012 | Kleshinski | Jun 2001 | B1 |
6261320 | Tam et al. | Jul 2001 | B1 |
6261620 | Leadbeater | Jul 2001 | B1 |
6283994 | Moe et al. | Sep 2001 | B1 |
6283995 | Moe et al. | Sep 2001 | B1 |
6287334 | Moll et al. | Sep 2001 | B1 |
6328763 | Love et al. | Dec 2001 | B1 |
6334873 | Lane et al. | Jan 2002 | B1 |
6336937 | Vonesh et al. | Jan 2002 | B1 |
6352552 | Levinson et al. | Mar 2002 | B1 |
6379382 | Jun | Apr 2002 | B1 |
6436132 | Patel et al. | Aug 2002 | B1 |
6454798 | Moe | Sep 2002 | B1 |
6454799 | Schreck | Sep 2002 | B1 |
6461382 | Cao | Oct 2002 | B1 |
6461665 | Scholander | Oct 2002 | B1 |
6482228 | Norred | Nov 2002 | B1 |
6488701 | Nolting et al. | Dec 2002 | B1 |
6541589 | Baillie | Apr 2003 | B1 |
6558418 | Carpentier et al. | May 2003 | B2 |
6562069 | Cai et al. | May 2003 | B2 |
6582464 | Gabbay | Jun 2003 | B2 |
6613086 | Moe et al. | Sep 2003 | B1 |
6620190 | Colone | Sep 2003 | B1 |
6626939 | Burnside et al. | Sep 2003 | B1 |
6645244 | Shu et al. | Nov 2003 | B2 |
6666885 | Moe | Dec 2003 | B2 |
6673102 | Vonesh et al. | Jan 2004 | B1 |
6673107 | Brandt et al. | Jan 2004 | B1 |
6726715 | Sutherland | Apr 2004 | B2 |
6730118 | Spenser et al. | May 2004 | B2 |
6730120 | Berg et al. | May 2004 | B2 |
6755856 | Fierens et al. | Jun 2004 | B2 |
6755857 | Peterson et al. | Jun 2004 | B2 |
6758858 | McCrea et al. | Jul 2004 | B2 |
6890350 | Walak | May 2005 | B1 |
6893460 | Spenser et al. | May 2005 | B2 |
6916338 | Speziali | Jul 2005 | B2 |
6936067 | Buchanan | Aug 2005 | B2 |
6953332 | Kurk et al. | Oct 2005 | B1 |
7022132 | Kocur | Apr 2006 | B2 |
7049380 | Chang et al. | May 2006 | B1 |
7083642 | Sirhan et al. | Aug 2006 | B2 |
7105018 | Yip et al. | Sep 2006 | B1 |
7137184 | Schreck | Nov 2006 | B2 |
7163556 | Xie et al. | Jan 2007 | B2 |
7238200 | Lee et al. | Jul 2007 | B2 |
7247167 | Gabbay | Jul 2007 | B2 |
7306729 | Bacino et al. | Dec 2007 | B2 |
7381218 | Schreck | Jun 2008 | B2 |
7419678 | Falotico | Sep 2008 | B2 |
7462675 | Chang et al. | Dec 2008 | B2 |
7510575 | Spenser et al. | Mar 2009 | B2 |
7513909 | Lane et al. | Apr 2009 | B2 |
7531611 | Sabol et al. | May 2009 | B2 |
7563277 | Case et al. | Jul 2009 | B2 |
7708775 | Rowe et al. | May 2010 | B2 |
7727274 | Zilla et al. | Jun 2010 | B2 |
7758640 | Vesely | Jul 2010 | B2 |
7780725 | Haug et al. | Aug 2010 | B2 |
7789908 | Sowinski et al. | Sep 2010 | B2 |
7803186 | Li et al. | Sep 2010 | B1 |
7811314 | Fierens et al. | Oct 2010 | B2 |
7815763 | Fierens et al. | Oct 2010 | B2 |
7879085 | Sowinski et al. | Feb 2011 | B2 |
7887562 | Young et al. | Feb 2011 | B2 |
7914569 | Nguyen et al. | Mar 2011 | B2 |
7927364 | Fierens et al. | Apr 2011 | B2 |
7927365 | Fierens et al. | Apr 2011 | B2 |
7935141 | Randall et al. | May 2011 | B2 |
7967829 | Gunderson et al. | Jun 2011 | B2 |
7967853 | Eidenschink et al. | Jun 2011 | B2 |
7993394 | Hariton et al. | Aug 2011 | B2 |
8048440 | Chang et al. | Nov 2011 | B2 |
8062359 | Marquez et al. | Nov 2011 | B2 |
8092523 | Li et al. | Jan 2012 | B2 |
8167935 | McGuckin, Jr. et al. | May 2012 | B2 |
8226710 | Nguyen et al. | Jul 2012 | B2 |
8246678 | Salahieh et al. | Aug 2012 | B2 |
8252037 | Styrc et al. | Aug 2012 | B2 |
8303647 | Case | Nov 2012 | B2 |
8349000 | Schreck | Jan 2013 | B2 |
8409274 | Li et al. | Apr 2013 | B2 |
8475512 | Hunt | Jul 2013 | B2 |
8545525 | Surti et al. | Oct 2013 | B2 |
8568475 | Nguyen et al. | Oct 2013 | B2 |
8585753 | Scanlon et al. | Nov 2013 | B2 |
8585757 | Agathos | Nov 2013 | B2 |
8628566 | Eberhardt et al. | Jan 2014 | B2 |
8637144 | Ford | Jan 2014 | B2 |
8709077 | Schreck | Apr 2014 | B2 |
8722178 | Ashmead et al. | May 2014 | B2 |
8728103 | Surti et al. | May 2014 | B2 |
8728154 | Alkhatib | May 2014 | B2 |
8784481 | Alkhatib et al. | Jul 2014 | B2 |
8801774 | Silverman | Aug 2014 | B2 |
8808848 | Bacino | Aug 2014 | B2 |
8845709 | Styrc et al. | Sep 2014 | B2 |
8845721 | Braido et al. | Sep 2014 | B2 |
8852272 | Gross et al. | Oct 2014 | B2 |
8870948 | Erzberger et al. | Oct 2014 | B1 |
8936634 | Irwin et al. | Jan 2015 | B2 |
8945212 | Bruchman et al. | Feb 2015 | B2 |
8961599 | Bruchman et al. | Feb 2015 | B2 |
8992608 | Haug et al. | Mar 2015 | B2 |
9039757 | McLean et al. | May 2015 | B2 |
9101469 | Bruchman et al. | Aug 2015 | B2 |
9107771 | Wubbeling et al. | Aug 2015 | B2 |
9125740 | Morriss et al. | Sep 2015 | B2 |
9139669 | Xu et al. | Sep 2015 | B2 |
9144492 | Bruchman et al. | Sep 2015 | B2 |
9168131 | Yohanan et al. | Oct 2015 | B2 |
9198787 | Kratzberg et al. | Dec 2015 | B2 |
9241695 | Peavey et al. | Jan 2016 | B2 |
9283072 | Bruchman et al. | Mar 2016 | B2 |
9295552 | McLean et al. | Mar 2016 | B2 |
9314355 | Styrc et al. | Apr 2016 | B2 |
9345601 | Jantzen et al. | May 2016 | B2 |
9375308 | Norris | Jun 2016 | B2 |
9393110 | Levi et al. | Jul 2016 | B2 |
9398952 | Bruchman et al. | Jul 2016 | B2 |
9399085 | Cleek et al. | Jul 2016 | B2 |
9504565 | Armstrong | Nov 2016 | B2 |
9554786 | Carley et al. | Jan 2017 | B2 |
9554900 | Bruchman et al. | Jan 2017 | B2 |
9597181 | Christianson et al. | Mar 2017 | B2 |
9629718 | Gloss et al. | Apr 2017 | B2 |
9681948 | Levi et al. | Jun 2017 | B2 |
9737398 | Bruchman et al. | Aug 2017 | B2 |
9737422 | Armstrong et al. | Aug 2017 | B2 |
9743932 | Amplatz et al. | Aug 2017 | B2 |
9795496 | Armstrong et al. | Oct 2017 | B2 |
9801712 | Bruchman et al. | Oct 2017 | B2 |
9827089 | Bruchman et al. | Nov 2017 | B2 |
9827094 | Bennett | Nov 2017 | B2 |
9839540 | Armstrong et al. | Dec 2017 | B2 |
9855141 | Dienno et al. | Jan 2018 | B2 |
9931193 | Cully et al. | Apr 2018 | B2 |
9931204 | Rothstein et al. | Apr 2018 | B2 |
9937037 | Dienno et al. | Apr 2018 | B2 |
9968443 | Bruchman et al. | May 2018 | B2 |
10039638 | Bruchman et al. | Aug 2018 | B2 |
10166128 | Armstrong et al. | Jan 2019 | B2 |
10279084 | Goepfrich et al. | May 2019 | B2 |
10285808 | Bruchman et al. | May 2019 | B2 |
10314697 | Gassler | Jun 2019 | B2 |
10321986 | Bruchman et al. | Jun 2019 | B2 |
10335298 | Armstrong et al. | Jul 2019 | B2 |
10342659 | Bennett | Jul 2019 | B2 |
10368984 | Armstrong | Aug 2019 | B2 |
10376360 | Bruchman et al. | Aug 2019 | B2 |
10441416 | Oba et al. | Oct 2019 | B2 |
10463478 | Bruchman et al. | Nov 2019 | B2 |
10507124 | Armstrong et al. | Dec 2019 | B2 |
10639144 | Bruchman et al. | May 2020 | B2 |
10660745 | Bruchman et al. | May 2020 | B2 |
10881507 | Bruchman et al. | Jan 2021 | B2 |
10980633 | Dienno et al. | Apr 2021 | B2 |
11020221 | Arcaro et al. | Jun 2021 | B2 |
11039917 | Bruchman et al. | Jun 2021 | B2 |
D926322 | Bennett et al. | Jul 2021 | S |
11065112 | Gassler | Jul 2021 | B2 |
11090153 | Haarer et al. | Aug 2021 | B2 |
11109963 | Dienno et al. | Sep 2021 | B2 |
11123183 | Benneii et al. | Sep 2021 | B2 |
20010053929 | Vonesh et al. | Dec 2001 | A1 |
20020045936 | Moe | Apr 2002 | A1 |
20020055773 | Campbell et al. | May 2002 | A1 |
20020076542 | Kramer et al. | Jun 2002 | A1 |
20020082687 | Moe | Jun 2002 | A1 |
20020133226 | Marquez et al. | Sep 2002 | A1 |
20020183840 | Lapeyre et al. | Dec 2002 | A1 |
20020198588 | Armstrong et al. | Dec 2002 | A1 |
20020198594 | Schreck | Dec 2002 | A1 |
20030014105 | Cao | Jan 2003 | A1 |
20030027332 | Lafrance et al. | Feb 2003 | A1 |
20030055494 | Bezuidenhout et al. | Mar 2003 | A1 |
20030055496 | Cai et al. | Mar 2003 | A1 |
20030060871 | Hill et al. | Mar 2003 | A1 |
20030074052 | Besselink et al. | Apr 2003 | A1 |
20030097175 | O'Connor et al. | May 2003 | A1 |
20030114913 | Spenser et al. | Jun 2003 | A1 |
20030180488 | Lim et al. | Sep 2003 | A1 |
20030229394 | Ogle et al. | Dec 2003 | A1 |
20040024442 | Sowinski et al. | Feb 2004 | A1 |
20040024448 | Chang et al. | Feb 2004 | A1 |
20040024451 | Johnson et al. | Feb 2004 | A1 |
20040026245 | Agarwal et al. | Feb 2004 | A1 |
20040039436 | Spenser et al. | Feb 2004 | A1 |
20040044400 | Cheng et al. | Mar 2004 | A1 |
20040044401 | Bales et al. | Mar 2004 | A1 |
20040133266 | Clerc et al. | Jul 2004 | A1 |
20040170782 | Wang et al. | Sep 2004 | A1 |
20040176839 | Huynh et al. | Sep 2004 | A1 |
20040224442 | Grigg | Nov 2004 | A1 |
20040243222 | Osborne et al. | Dec 2004 | A1 |
20040260277 | Maguire | Dec 2004 | A1 |
20040260393 | Rahdert et al. | Dec 2004 | A1 |
20050027348 | Case et al. | Feb 2005 | A1 |
20050080476 | Gunderson et al. | Apr 2005 | A1 |
20050119722 | Styrc et al. | Jun 2005 | A1 |
20050137680 | Ortiz et al. | Jun 2005 | A1 |
20050137682 | Justino | Jun 2005 | A1 |
20050261765 | Liddicoat | Nov 2005 | A1 |
20050283224 | King | Dec 2005 | A1 |
20060008497 | Gabbay | Jan 2006 | A1 |
20060009835 | Osborne et al. | Jan 2006 | A1 |
20060015171 | Armstrong | Jan 2006 | A1 |
20060036311 | Nakayama et al. | Feb 2006 | A1 |
20060041091 | Chang et al. | Feb 2006 | A1 |
20060106337 | Blankenship | May 2006 | A1 |
20060118236 | House et al. | Jun 2006 | A1 |
20060122693 | Biadillah et al. | Jun 2006 | A1 |
20060135985 | Cox et al. | Jun 2006 | A1 |
20060154365 | Ratcliffe et al. | Jul 2006 | A1 |
20060161241 | Barbut et al. | Jul 2006 | A1 |
20060190070 | Dieck et al. | Aug 2006 | A1 |
20060229718 | Marquez | Oct 2006 | A1 |
20060229719 | Marquez et al. | Oct 2006 | A1 |
20060259133 | Sowinski et al. | Nov 2006 | A1 |
20060259136 | Nguyen et al. | Nov 2006 | A1 |
20060265053 | Hunt | Nov 2006 | A1 |
20060271091 | Campbell et al. | Nov 2006 | A1 |
20060276813 | Greenberg | Dec 2006 | A1 |
20060276883 | Greenberg et al. | Dec 2006 | A1 |
20060276888 | Lee et al. | Dec 2006 | A1 |
20060282162 | Nguyen et al. | Dec 2006 | A1 |
20060290027 | O'Connor et al. | Dec 2006 | A1 |
20070010876 | Salahieh et al. | Jan 2007 | A1 |
20070012624 | Bacino et al. | Jan 2007 | A1 |
20070021826 | Case et al. | Jan 2007 | A1 |
20070060999 | Randall et al. | Mar 2007 | A1 |
20070118210 | Pinchuk | May 2007 | A1 |
20070129786 | Beach et al. | Jun 2007 | A1 |
20070207186 | Scanlon et al. | Sep 2007 | A1 |
20070207816 | Spain, Jr. | Sep 2007 | A1 |
20070208421 | Quigley | Sep 2007 | A1 |
20070213800 | Fierens et al. | Sep 2007 | A1 |
20070244552 | Salahieh et al. | Oct 2007 | A1 |
20070250146 | Cully et al. | Oct 2007 | A1 |
20070250153 | Cully et al. | Oct 2007 | A1 |
20070254012 | Ludwig et al. | Nov 2007 | A1 |
20080009940 | Cribier | Jan 2008 | A1 |
20080026190 | King et al. | Jan 2008 | A1 |
20080039934 | Styrc | Feb 2008 | A1 |
20080051876 | Ta et al. | Feb 2008 | A1 |
20080065198 | Quintessenza | Mar 2008 | A1 |
20080071369 | Tuval et al. | Mar 2008 | A1 |
20080082154 | Tseng et al. | Apr 2008 | A1 |
20080097301 | Alpini et al. | Apr 2008 | A1 |
20080097401 | Trapp et al. | Apr 2008 | A1 |
20080097579 | Shanley et al. | Apr 2008 | A1 |
20080097582 | Shanley et al. | Apr 2008 | A1 |
20080119943 | Armstrong et al. | May 2008 | A1 |
20080133004 | White | Jun 2008 | A1 |
20080140178 | Rasmussen et al. | Jun 2008 | A1 |
20080195199 | Kheradvar et al. | Aug 2008 | A1 |
20080208327 | Rowe | Aug 2008 | A1 |
20080220041 | Brito et al. | Sep 2008 | A1 |
20080228263 | Ryan | Sep 2008 | A1 |
20080300678 | Eidenschink et al. | Dec 2008 | A1 |
20080319531 | Doran et al. | Dec 2008 | A1 |
20090005854 | Huang et al. | Jan 2009 | A1 |
20090030499 | Bebb et al. | Jan 2009 | A1 |
20090036976 | Beach et al. | Feb 2009 | A1 |
20090043373 | Arnault et al. | Feb 2009 | A1 |
20090104247 | Pacetti | Apr 2009 | A1 |
20090117334 | Sogard et al. | May 2009 | A1 |
20090138079 | Tuval et al. | May 2009 | A1 |
20090157175 | Benichou | Jun 2009 | A1 |
20090182413 | Burkart et al. | Jul 2009 | A1 |
20090240320 | Tuval et al. | Sep 2009 | A1 |
20090264997 | Salahieh et al. | Oct 2009 | A1 |
20090276039 | Meretei | Nov 2009 | A1 |
20090287305 | Amalaha | Nov 2009 | A1 |
20090292350 | Eberhardt et al. | Nov 2009 | A1 |
20090306762 | McCullagh et al. | Dec 2009 | A1 |
20090306766 | McDermott et al. | Dec 2009 | A1 |
20100016940 | Shokoohi et al. | Jan 2010 | A1 |
20100023114 | Chambers et al. | Jan 2010 | A1 |
20100036021 | Lee et al. | Feb 2010 | A1 |
20100036484 | Hariton et al. | Feb 2010 | A1 |
20100049294 | Zukowski et al. | Feb 2010 | A1 |
20100082094 | Quadri et al. | Apr 2010 | A1 |
20100094394 | Beach et al. | Apr 2010 | A1 |
20100094405 | Cottone | Apr 2010 | A1 |
20100106240 | Duggal et al. | Apr 2010 | A1 |
20100131056 | Lapeyre | May 2010 | A1 |
20100137998 | Sobrino-Serrano et al. | Jun 2010 | A1 |
20100145438 | Barone | Jun 2010 | A1 |
20100159171 | Clough | Jun 2010 | A1 |
20100168839 | Braido et al. | Jul 2010 | A1 |
20100185274 | Moaddeb et al. | Jul 2010 | A1 |
20100185277 | Braido et al. | Jul 2010 | A1 |
20100191320 | Straubinger et al. | Jul 2010 | A1 |
20100204781 | Alkhatib | Aug 2010 | A1 |
20100204785 | Alkhatib | Aug 2010 | A1 |
20100211165 | Schreck | Aug 2010 | A1 |
20100217382 | Chau et al. | Aug 2010 | A1 |
20100248324 | Xu et al. | Sep 2010 | A1 |
20100249923 | Alkhatib et al. | Sep 2010 | A1 |
20100256738 | Berglund | Oct 2010 | A1 |
20100262231 | Tuval et al. | Oct 2010 | A1 |
20100286760 | Beach et al. | Nov 2010 | A1 |
20100298931 | Quadri et al. | Nov 2010 | A1 |
20100305682 | Furst | Dec 2010 | A1 |
20110009953 | Luk et al. | Jan 2011 | A1 |
20110040366 | Goetz et al. | Feb 2011 | A1 |
20110054515 | Bridgeman et al. | Mar 2011 | A1 |
20110064781 | Cleek et al. | Mar 2011 | A1 |
20110087318 | Daugherty et al. | Apr 2011 | A1 |
20110160836 | Behan | Jun 2011 | A1 |
20110172784 | Richter et al. | Jul 2011 | A1 |
20110208283 | Rust | Aug 2011 | A1 |
20110218619 | Benichou et al. | Sep 2011 | A1 |
20110251678 | Eidenschink et al. | Oct 2011 | A1 |
20110257739 | Corbett | Oct 2011 | A1 |
20110282439 | Thill et al. | Nov 2011 | A1 |
20110295363 | Girard et al. | Dec 2011 | A1 |
20120035722 | Tuval | Feb 2012 | A1 |
20120078357 | Conklin | Mar 2012 | A1 |
20120083839 | Letac et al. | Apr 2012 | A1 |
20120089223 | Nguyen et al. | Apr 2012 | A1 |
20120101567 | Jansen | Apr 2012 | A1 |
20120101571 | Thambar et al. | Apr 2012 | A1 |
20120116496 | Chuter et al. | May 2012 | A1 |
20120116498 | Chuter et al. | May 2012 | A1 |
20120123529 | Levi et al. | May 2012 | A1 |
20120123530 | Carpentier et al. | May 2012 | A1 |
20120130468 | Khosravi et al. | May 2012 | A1 |
20120130471 | Shoemaker et al. | May 2012 | A1 |
20120185038 | Fish et al. | Jul 2012 | A1 |
20120253453 | Bruchman et al. | Oct 2012 | A1 |
20120290082 | Quint et al. | Nov 2012 | A1 |
20120323211 | Ogle et al. | Dec 2012 | A1 |
20120323315 | Bruchman et al. | Dec 2012 | A1 |
20130018456 | Li et al. | Jan 2013 | A1 |
20130018458 | Yohanan et al. | Jan 2013 | A1 |
20130079700 | Ballard et al. | Mar 2013 | A1 |
20130110229 | Bokeriya et al. | May 2013 | A1 |
20130116655 | Bacino et al. | May 2013 | A1 |
20130131780 | Armstrong et al. | May 2013 | A1 |
20130150956 | Yohanan et al. | Jun 2013 | A1 |
20130158647 | Norris et al. | Jun 2013 | A1 |
20130166021 | Bruchman et al. | Jun 2013 | A1 |
20130183515 | White | Jul 2013 | A1 |
20130184807 | Kovach et al. | Jul 2013 | A1 |
20130197624 | Armstrong et al. | Aug 2013 | A1 |
20130204347 | Armstrong et al. | Aug 2013 | A1 |
20130204360 | Gainor | Aug 2013 | A1 |
20130253466 | Campbell et al. | Sep 2013 | A1 |
20130297003 | Pinchuk | Nov 2013 | A1 |
20130338755 | Goetz et al. | Dec 2013 | A1 |
20140005771 | Braido et al. | Jan 2014 | A1 |
20140005773 | Wheatley | Jan 2014 | A1 |
20140031924 | Bruchman et al. | Jan 2014 | A1 |
20140031927 | Bruchman et al. | Jan 2014 | A1 |
20140094898 | Borck | Apr 2014 | A1 |
20140106951 | Brandon | Apr 2014 | A1 |
20140135897 | Cully et al. | May 2014 | A1 |
20140163671 | Bruchman et al. | Jun 2014 | A1 |
20140163673 | Bruchman et al. | Jun 2014 | A1 |
20140172066 | Goepfrich et al. | Jun 2014 | A1 |
20140172069 | Roeder et al. | Jun 2014 | A1 |
20140172077 | Bruchman et al. | Jun 2014 | A1 |
20140172078 | Bruchman et al. | Jun 2014 | A1 |
20140172079 | Bruchman et al. | Jun 2014 | A1 |
20140172082 | Bruchman et al. | Jun 2014 | A1 |
20140172083 | Bruchman et al. | Jun 2014 | A1 |
20140180400 | Bruchman et al. | Jun 2014 | A1 |
20140180402 | Bruchman et al. | Jun 2014 | A1 |
20140194968 | Zukowski | Jul 2014 | A1 |
20140222140 | Schreck | Aug 2014 | A1 |
20140236289 | Alkhatib | Aug 2014 | A1 |
20140277413 | Arnold et al. | Sep 2014 | A1 |
20140277418 | Miller | Sep 2014 | A1 |
20140296969 | Tegels et al. | Oct 2014 | A1 |
20140324160 | Benichou et al. | Oct 2014 | A1 |
20140324164 | Gross et al. | Oct 2014 | A1 |
20140330368 | Gloss et al. | Nov 2014 | A1 |
20140343670 | Bakis et al. | Nov 2014 | A1 |
20150005870 | Kovach et al. | Jan 2015 | A1 |
20150018944 | O'Connell et al. | Jan 2015 | A1 |
20150088250 | Zeng et al. | Mar 2015 | A1 |
20150105856 | Rowe et al. | Apr 2015 | A1 |
20150142100 | Morriss et al. | May 2015 | A1 |
20150157456 | Armstrong | Jun 2015 | A1 |
20150157770 | Cully et al. | Jun 2015 | A1 |
20150224231 | Bruchman et al. | Aug 2015 | A1 |
20150245910 | Righini et al. | Sep 2015 | A1 |
20150313871 | Li et al. | Nov 2015 | A1 |
20150366663 | Bruchman et al. | Dec 2015 | A1 |
20150366664 | Guttenberg et al. | Dec 2015 | A1 |
20160001469 | Bacchereti et al. | Jan 2016 | A1 |
20160015422 | De et al. | Jan 2016 | A1 |
20160074161 | Bennett | Mar 2016 | A1 |
20160113699 | Sverdlik et al. | Apr 2016 | A1 |
20160157998 | Bruchman et al. | Jun 2016 | A1 |
20160175095 | Dienno et al. | Jun 2016 | A1 |
20160175096 | Dienno et al. | Jun 2016 | A1 |
20160206424 | Al-Jilaihawi et al. | Jul 2016 | A1 |
20160213465 | Girard et al. | Jul 2016 | A1 |
20160235525 | Rothstein et al. | Aug 2016 | A1 |
20160310268 | Oba et al. | Oct 2016 | A1 |
20160317299 | Alkhatib | Nov 2016 | A1 |
20170027727 | Wuebbeling et al. | Feb 2017 | A1 |
20170042674 | Armstrong | Feb 2017 | A1 |
20170056169 | Johnson et al. | Mar 2017 | A1 |
20170065400 | Armstrong et al. | Mar 2017 | A1 |
20170095330 | Malewicz et al. | Apr 2017 | A1 |
20170095331 | Spenser et al. | Apr 2017 | A1 |
20170100236 | Robertson et al. | Apr 2017 | A1 |
20170105854 | Treacy et al. | Apr 2017 | A1 |
20170106176 | Taft et al. | Apr 2017 | A1 |
20170128199 | Gurovich et al. | May 2017 | A1 |
20170156859 | Chang et al. | Jun 2017 | A1 |
20170165066 | Rothstein | Jun 2017 | A1 |
20170165067 | Barajas-Torres et al. | Jun 2017 | A1 |
20170216062 | Armstrong et al. | Aug 2017 | A1 |
20170224481 | Spenser et al. | Aug 2017 | A1 |
20170252153 | Chau et al. | Sep 2017 | A1 |
20170348101 | Vaughn et al. | Dec 2017 | A1 |
20180021128 | Bruchman et al. | Jan 2018 | A1 |
20180021129 | Peterson et al. | Jan 2018 | A1 |
20180125646 | Bruchman et al. | May 2018 | A1 |
20180177583 | Cully et al. | Jun 2018 | A1 |
20180221144 | Bruchman et al. | Aug 2018 | A1 |
20180318070 | Bruchman et al. | Nov 2018 | A1 |
20190076245 | Arcaro et al. | Mar 2019 | A1 |
20190091014 | Arcaro et al. | Mar 2019 | A1 |
20190091015 | Dienno et al. | Mar 2019 | A1 |
20190110893 | Haarer et al. | Apr 2019 | A1 |
20190125517 | Cully et al. | May 2019 | A1 |
20190125528 | Busalacchi et al. | May 2019 | A1 |
20190125530 | Arcaro et al. | May 2019 | A1 |
20190125531 | Bennett et al. | May 2019 | A1 |
20190125534 | Arcaro et al. | May 2019 | A1 |
20190209292 | Bruchman et al. | Jul 2019 | A1 |
20190209739 | Goepfrich et al. | Jul 2019 | A1 |
20190216592 | Cully et al. | Jul 2019 | A1 |
20190247185 | Gassler | Aug 2019 | A1 |
20190254815 | Bruchman et al. | Aug 2019 | A1 |
20190269505 | Bruchman et al. | Sep 2019 | A1 |
20190314154 | Armstrong | Oct 2019 | A1 |
20190328525 | Noe et al. | Oct 2019 | A1 |
20200000578 | Bruchman et al. | Jan 2020 | A1 |
20200022828 | Armstrong et al. | Jan 2020 | A1 |
20200179663 | McDaniel et al. | Jun 2020 | A1 |
20200237497 | Silverman et al. | Jul 2020 | A1 |
20200237505 | Bruchman et al. | Jul 2020 | A1 |
20200246137 | Bruchman et al. | Aug 2020 | A1 |
20200276014 | Burkart et al. | Sep 2020 | A1 |
20210121289 | Bruchman et al. | Apr 2021 | A1 |
20210177589 | Arcaro et al. | Jun 2021 | A1 |
20210205074 | Bruchman et al. | Jul 2021 | A1 |
20210307905 | Arcaro et al. | Oct 2021 | A1 |
20210338422 | Dienno et al. | Nov 2021 | A1 |
20210346156 | Haarer et al. | Nov 2021 | A1 |
20210361420 | Bennett et al. | Nov 2021 | A1 |
20210393399 | Arcaro et al. | Dec 2021 | A1 |
20220000611 | Arcaro et al. | Jan 2022 | A1 |
20220023032 | Bruchman et al. | Jan 2022 | A1 |
Number | Date | Country |
---|---|---|
2013363172 | Jul 2015 | AU |
2017202405 | Apr 2017 | AU |
2462509 | Apr 2003 | CA |
2849030 | Apr 2013 | CA |
2878691 | Jan 2014 | CA |
2964546 | Jan 2014 | CA |
2960034 | Mar 2016 | CA |
101057796 | Oct 2007 | CN |
101091675 | Dec 2007 | CN |
101188985 | May 2008 | CN |
101374477 | Feb 2009 | CN |
101420913 | Apr 2009 | CN |
101849863 | Oct 2010 | CN |
101902989 | Dec 2010 | CN |
101926699 | Dec 2010 | CN |
201744060 | Feb 2011 | CN |
102015009 | Apr 2011 | CN |
102119013 | Jul 2011 | CN |
102292053 | Dec 2011 | CN |
102438546 | May 2012 | CN |
102573703 | Jul 2012 | CN |
102652694 | Sep 2012 | CN |
102764169 | Nov 2012 | CN |
102791223 | Nov 2012 | CN |
102883684 | Jan 2013 | CN |
103079498 | May 2013 | CN |
103228232 | Jul 2013 | CN |
103237524 | Aug 2013 | CN |
103384505 | Nov 2013 | CN |
103732183 | Apr 2014 | CN |
103781439 | May 2014 | CN |
103945796 | Jul 2014 | CN |
104114127 | Oct 2014 | CN |
104487023 | Apr 2015 | CN |
104507417 | Apr 2015 | CN |
105007955 | Oct 2015 | CN |
105101911 | Nov 2015 | CN |
105263445 | Jan 2016 | CN |
105792780 | Jul 2016 | CN |
106668949 | May 2017 | CN |
106714733 | May 2017 | CN |
106794065 | May 2017 | CN |
107106294 | Aug 2017 | CN |
107690323 | Feb 2018 | CN |
212013000104 | Nov 2014 | DE |
0293090 | Nov 1988 | EP |
0313263 | Apr 1989 | EP |
0582870 | Feb 1994 | EP |
0775472 | May 1997 | EP |
0815806 | Jan 1998 | EP |
0893108 | Jan 1999 | EP |
1318775 | Jun 2003 | EP |
1666003 | Jun 2006 | EP |
1395205 | Jul 2008 | EP |
1235537 | Dec 2008 | EP |
2193762 | Jun 2010 | EP |
2255750 | Dec 2010 | EP |
2359774 | Aug 2011 | EP |
2400923 | Jan 2012 | EP |
2591100 | May 2013 | EP |
2109417 | Nov 2013 | EP |
3142608 | Mar 2017 | EP |
3797738 | Mar 2021 | EP |
2591100 | Jun 1987 | FR |
2312485 | Oct 1997 | GB |
2513194 | Oct 2014 | GB |
44-032400 | Dec 1969 | JP |
196932400 | Dec 1969 | JP |
02-000645 | Jan 1990 | JP |
09-241412 | Sep 1997 | JP |
10-507097 | Jul 1998 | JP |
11-290448 | Oct 1999 | JP |
11-512635 | Nov 1999 | JP |
2000511459 | Sep 2000 | JP |
2000513248 | Oct 2000 | JP |
2001-508641 | Jul 2001 | JP |
2001-508681 | Jul 2001 | JP |
2001-509702 | Jul 2001 | JP |
2001-511030 | Aug 2001 | JP |
2002-525169 | Aug 2002 | JP |
2002-541915 | Dec 2002 | JP |
2004-510471 | Apr 2004 | JP |
2005500101 | Jan 2005 | JP |
2005-512611 | May 2005 | JP |
2007-526098 | Sep 2007 | JP |
2007536989 | Dec 2007 | JP |
2008-506459 | Mar 2008 | JP |
2008-535572 | Sep 2008 | JP |
4335487 | Sep 2009 | JP |
2010-500107 | Jan 2010 | JP |
2010-504174 | Feb 2010 | JP |
2010-517623 | May 2010 | JP |
2010-528761 | Aug 2010 | JP |
2010-188189 | Sep 2010 | JP |
2010-535075 | Nov 2010 | JP |
2010536527 | Dec 2010 | JP |
2012504031 | Feb 2012 | JP |
2012152563 | Aug 2012 | JP |
2013-543399 | Dec 2013 | JP |
2014-513585 | Jun 2014 | JP |
2014517720 | Jul 2014 | JP |
2016-501104 | Jan 2016 | JP |
2016-518948 | Jun 2016 | JP |
2017-527397 | Sep 2017 | JP |
2018-079352 | May 2018 | JP |
6392778 | Sep 2018 | JP |
6802300 | Dec 2020 | JP |
2124986 | Jan 1999 | RU |
2434604 | Nov 2011 | RU |
9413224 | Jun 1994 | WO |
9416802 | Aug 1994 | WO |
9505555 | Feb 1995 | WO |
9509586 | Apr 1995 | WO |
1996002212 | Feb 1996 | WO |
9607370 | Mar 1996 | WO |
9640348 | Dec 1996 | WO |
9710871 | Mar 1997 | WO |
9926558 | Jun 1999 | WO |
0018333 | Apr 2000 | WO |
0041649 | Jul 2000 | WO |
0047271 | Aug 2000 | WO |
2000062716 | Oct 2000 | WO |
0128453 | Apr 2001 | WO |
0141679 | Jun 2001 | WO |
0164278 | Sep 2001 | WO |
0174272 | Oct 2001 | WO |
2002024118 | Mar 2002 | WO |
2002024119 | Mar 2002 | WO |
2002045933 | Jun 2002 | WO |
0260506 | Aug 2002 | WO |
2002100301 | Dec 2002 | WO |
0303946 | Jan 2003 | WO |
0307795 | Jan 2003 | WO |
2003007795 | Jan 2003 | WO |
0347468 | Jun 2003 | WO |
2003047468 | Jun 2003 | WO |
03090834 | Nov 2003 | WO |
2004000375 | Dec 2003 | WO |
2005112827 | Dec 2005 | WO |
2006019626 | Feb 2006 | WO |
2006058322 | Jun 2006 | WO |
2006108090 | Oct 2006 | WO |
2007016251 | Feb 2007 | WO |
2008021002 | Feb 2008 | WO |
2008028964 | Mar 2008 | WO |
2008036870 | Mar 2008 | WO |
2008049045 | Apr 2008 | WO |
2008052421 | May 2008 | WO |
2008091589 | Jul 2008 | WO |
2008021006 | Aug 2008 | WO |
2008097589 | Aug 2008 | WO |
2008097592 | Aug 2008 | WO |
2008150529 | Dec 2008 | WO |
2009017827 | Feb 2009 | WO |
2009029199 | Mar 2009 | WO |
2009045332 | Apr 2009 | WO |
2009100210 | Aug 2009 | WO |
2009108355 | Sep 2009 | WO |
2010006783 | Jan 2010 | WO |
2010008570 | Jan 2010 | WO |
2010030766 | Mar 2010 | WO |
2010037141 | Apr 2010 | WO |
2010086460 | Aug 2010 | WO |
2010132707 | Nov 2010 | WO |
2010150208 | Dec 2010 | WO |
2010057262 | Jun 2011 | WO |
2011098565 | Aug 2011 | WO |
2011109450 | Sep 2011 | WO |
2011109801 | Sep 2011 | WO |
2011112706 | Sep 2011 | WO |
2012004460 | Jan 2012 | WO |
2012011261 | Jan 2012 | WO |
2012040643 | Mar 2012 | WO |
2012047644 | Apr 2012 | WO |
2012065080 | May 2012 | WO |
2012082952 | Jun 2012 | WO |
2012099979 | Jul 2012 | WO |
2012116368 | Aug 2012 | WO |
2012110767 | Aug 2012 | WO |
2012135603 | Oct 2012 | WO |
2012158944 | Nov 2012 | WO |
2012167131 | Dec 2012 | WO |
2013074663 | May 2013 | WO |
2013074990 | May 2013 | WO |
2013096854 | Jun 2013 | WO |
2013109337 | Jul 2013 | WO |
2014018189 | Jan 2014 | WO |
2014018432 | Jan 2014 | WO |
2014099150 | Jun 2014 | WO |
2014099163 | Jun 2014 | WO |
2014099722 | Jun 2014 | WO |
2014144937 | Sep 2014 | WO |
2015045002 | Apr 2015 | WO |
2015085138 | Jun 2015 | WO |
2015171743 | Nov 2015 | WO |
2015173794 | Nov 2015 | WO |
2016028591 | Feb 2016 | WO |
2016044223 | Mar 2016 | WO |
2016100913 | Jun 2016 | WO |
2016172349 | Oct 2016 | WO |
2016186909 | Nov 2016 | WO |
2017038145 | Mar 2017 | WO |
2017096157 | Jun 2017 | WO |
2019067219 | Apr 2019 | WO |
2019067220 | Apr 2019 | WO |
2019074607 | Apr 2019 | WO |
2019074869 | Apr 2019 | WO |
2019089138 | May 2019 | WO |
Entry |
---|
Cardiac Surgery in the Adult, Third Edition, Chapter 2 2008. |
EPO Form 1002 for EP16196687.4 Filed Dec. 28, 2016. |
Forward citations for E12 obtained from: https://scholar.google.com/scholar?cites=5981833429320176658&assdt=2005&sciodt=0,58hl= en. |
International Search Report and Written Opinion received for PCT Application No. PCT/US2020/020550, dated Jun. 9, 2020, 12 pages. |
European Search Report from EP16196687.4, dated Nov. 21, 2017, 5 pages. |
International Preliminary Report on Patentability from PCT/US2015/045002, dated Mar. 2, 2017, 11 pages. |
International Preliminary Report on Patentability issued in PCT/US2017/047174, dated Mar. 7, 2019, 9 pages. |
International Search Report and Written Opinion for PCT/US2014/068727 dated Mar. 2, 2015, corresponding to U.S. Appl. No. 14/561,148; 12 pages. |
International Search Report and Written Opinion for PCT/US2015/050113, dated Nov. 24, 2015, 14 pages. |
International Search Report and Written Opinion from PCT/US2018/050768, dated Dec. 17, 2018, 12 pages. |
International Search Report and Written Opinion from PCT/US2018/050786 dated Dec. 14, 2018, 13 pages. |
International Search Report and Written Opinion from PCT/US2018/053278, dated Dec. 19, 2018, 12 pages. |
International Search Report and Written Opinion issued in PCT/US2018/050764, dated Nov. 23, 2018, 13 pages. |
International Search Report and Written Opinion issued in PCT/US2018/050766, dated Mar. 11, 2019, 16 pages. |
International Search Report and Written Opinion issued in PCT/US2018/050778, dated Nov. 29, 2018, 11 pages. |
International Search Report for PCT/US2013/046389 dated Jan. 21, 2014, corresponding to U.S. Appl. No. 13/797,633; 18 pages. |
International Search Report for PCT/US2013/051431 dated Jan. 20, 2014, corresponding to U.S. Appl. No. 13/797,526; 6 pages. |
International Search Report for PCT/US2013/068390 dated Apr. 29, 2014, corresponding to U.S. Appl. No. 13/835,988, 7 pages. |
International Search Report for PCT/US2013/068780 dated Feb. 27, 2014, corresponding to U.S. Appl. No. 13/869,878, 4 pages. |
International Search Report for PCT/US2013/071632 dated Apr. 28, 2014, corresponding to U.S. Appl. No. 13/841,334, 6 pages. |
International Search Report for PCT/US2013/074962 dated Feb. 27, 2014, 4 pages. |
International Search Report for PCT/US2013/075274 dated Feb. 27, 2014, corresponding to U.S. Appl. No. 13/843,196, 5 pages. |
International Search Report for PCT/US2013/075380 dated Mar. 6, 2014, 5 pages. |
International Search Report for PCT/US2013/076504 dated Apr. 28, 2014, corresponding to U.S. Appl. No. 14/133,491, 7 pages. |
International Search Report for PCT/US2013/076688 dated Feb. 27, 2014, 5 pages. |
Google Image Search Results, “S-Shaped”, accessed Nov. 1, 2013. |
International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US15/50113, dated Mar. 30, 2017, 9 pages. |
International Preliminary Reporton Patentability received for PCT Patent Application No. PCT/US2020/027921, dated Oct. 21, 2021, 11 pages. |
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2020/027921, dated Jul. 24, 2020, 16 pages. |
Nakayama, Yasuhide. Microporous Stent Achieves Brain Aneurysm Occlusion Without Disturbing Branching Flow. NeuroNews Nov. 2012; 8:1-2. |
Nishi S, Nakayama Y, Ishibashi-Ueda FI, Okamoto Y, Yoshida M. Development of microporous self-expanding stent grafts for treating cerebral aneurysms: designing micropores to control intimal hyperplasia. J Artif Organs 2011; 14:348-356. |
Clough, Norman E. Introducing a New Family of GORE ePTFE Fibers (2007), pp. 1-10. |
Mano Thubrikar, “The Aortic Valve”, Chapter 1: Geometry of the Aortic Valve, CRC Press, Inc., Informa Healthcare, 2011, 40 pages. |
Opposition from EP16196687.4, mailed on Dec. 12, 2019, 38 pages. |
Opposition from EP17187595.8, filed Sep. 12, 2019, 50 pages. |
Number | Date | Country | |
---|---|---|---|
20190374339 A1 | Dec 2019 | US |
Number | Date | Country | |
---|---|---|---|
62050628 | Sep 2014 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15791562 | Oct 2017 | US |
Child | 16446343 | US | |
Parent | 14853654 | Sep 2015 | US |
Child | 15791562 | US |